Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Uridine phosphorylase (UPase, EC 2.4.2.3) is an enzyme that catalyzes the reversible phosphorolysis of uridine to uracil and alpha-D-ribose 1-phosphate. It belongs to the glycosyltransferase family and plays a central role in pyrimidine metabolism by participating in the salvage pathway for pyrimidine nucleosides. Its activity is often elevated in various tumor tissues, enhancing sensitivity to chemotherapeutic agents like 5-FU. Inhibitors of UP or genetic disruption can modulate drug toxicity profiles or rescue normal tissues from chemotherapeutic side effects.
Phosphorolysis of uridine to uracil and alpha-D-ribose 1-phosphate; activation of fluoropyrimidines.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Uridine Phosphorylase (UPase).